{
 "context": "The following article called 'Trovagene reports 4Q loss' was published on 2018-02-27. The body of the article is as follows:\n    \nSAN DIEGO (AP) _ Trovagene Inc. (TROV) on Monday reported a loss of $2.6 million in its fourth quarter.\nOn a per-share basis, the San Diego-based company said it had a loss of 6 cents.\nThe molecular diagnostic company posted revenue of $185,000 in the period.\nFor the year, the company reported that its loss narrowed to $24.9 million, or 72 cents per share. Revenue was reported as $505,000.\nIn the final minutes of trading on Monday, the company's shares hit 32 cents. A year ago, they were trading at $2.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on TROV at https://www.zacks.com/ap/TROV\n\n    The day before the article was published, the stock price of Ampco-Pittsburgh Corporation was 10.949999809265137 and the day after the article was published, the stock price of Ampco-Pittsburgh Corporation was ",
 "expected": "10.199999809265137",
 "date": "2018-02-27",
 "ticker": "AP",
 "company": "Ampco-Pittsburgh Corporation",
 "url": "https://www.cnbc.com/2018/02/26/the-associated-press-trovagene-reports-4q-loss.html"
}